FDA Approved: AGGRASTAT — Supplemental Application (Medicure International Inc)

View source ↗

Summary

FDA approved a supplemental application for AGGRASTAT (tirofiban) submitted by Medicure International Inc, resulting in changes to the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Myocardial Infarction

Drugs mentioned

• Aggrastat (tirofiban)

Snippet

SUPPL AP for AGGRASTAT (TIROFIBAN)